Drug Search Results
More Filters [+]

Gadopentetic acid

Alternative Names: gadopentetic acid
Latest Update: 2023-10-13
Latest Update Note: News Article

Product Description

Mechanisms of Action: Contrast Agent

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Austria | Brazil | Bulgaria | Canada | Colombia | Cyprus | Dominican Republic | Hungary | Iceland | India | Ireland | Italy | Korea | Lithuania | Malta | New Zealand | Peru | Portugal | Russia | Singapore | Slovenia | Sweden | Switzerland | Thailand | Turkey | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Gadopentetic acid

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events